Search research articles
Contact Us
Filters
Showing results (111-120 of 137) with videos related to
Page
of 14
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 12, 2004
Single-chain Fv-streptavidin substantially improved therapeutic index in multistep targeting directed at disialoganglioside GD2
Nai-Kong V Cheung, Shakeel Modak, Yukang Lin, et al.
The Journal of Clinical Investigation
|
August 7, 2012
Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment
Nidale Tarek, Jean-Benoit Le Luduec, Meighan M Gallagher, et al.
International Journal of Cancer
|
August 21, 2023
Stage 4N neuroblastoma before and during the era of anti-G<sub>D2</sub> immunotherapy
Brian H Kushner, Michael P LaQuaglia, Fiorella Iglesias Cardenas, et al.
Pediatric Blood & Cancer
|
November 9, 2022
Clinical outcomes of pediatric patients receiving multimodality treatment of second central nervous system relapse of neuroblastoma
Kathryn R Tringale, Suzanne L Wolden, Dana L Casey, et al.
Practical Radiation Oncology
|
February 4, 2024
Intraoperative Radiation Therapy for Relapsed or Refractory High-Risk Neuroblastoma: A 27-Year Experience
Brianna Conte, Dana L Casey, Kathryn R Tringale, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 21, 2025
Local Control With Reduced-Dose Radiation Therapy for High-Risk Neuroblastoma: Results From a Prospective Clinical Trial
Christopher B Jackson, Dana L Casey, Brian H Kushner, et al.
Journal of Neuro-Oncology
|
November 6, 2009
Compartmental intrathecal radioimmunotherapy: results for treatment for metastatic CNS neuroblastoma
Kim Kramer, Brian H Kushner, Shakeel Modak, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 15, 2017
Biodistribution and Dosimetry of <sup>18</sup>F-Meta-Fluorobenzylguanidine: A First-in-Human PET/CT Imaging Study of Patients with Neuroendocrine Malignancies
Neeta Pandit-Taskar, Pat Zanzonico, Kevin D Staton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 29, 2020
B7H3-Directed Intraperitoneal Radioimmunotherapy With Radioiodinated Omburtamab for Desmoplastic Small Round Cell Tumor and Other Peritoneal Tumors: Results of a Phase I Study
Shakeel Modak, Pat Zanzonico, Milan Grkovski, et al.
Research Square
|
November 21, 2023
Targeting GD2-positive Refractory/Resistant Neuroblastoma and Osteosarcoma with Anti- CD3 x Anti-GD2 Bispecific Antibody Armed T cells
Maxim Yankelevich, Archana Thakur, Shakeel Modak, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 137) with videos related to
Sort By:
Page
of 14
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 12, 2004
Single-chain Fv-streptavidin substantially improved therapeutic index in multistep targeting directed at disialoganglioside GD2
Nai-Kong V Cheung, Shakeel Modak, Yukang Lin, et al.
The Journal of Clinical Investigation
|
August 7, 2012
Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment
Nidale Tarek, Jean-Benoit Le Luduec, Meighan M Gallagher, et al.
International Journal of Cancer
|
August 21, 2023
Stage 4N neuroblastoma before and during the era of anti-G<sub>D2</sub> immunotherapy
Brian H Kushner, Michael P LaQuaglia, Fiorella Iglesias Cardenas, et al.
Pediatric Blood & Cancer
|
November 9, 2022
Clinical outcomes of pediatric patients receiving multimodality treatment of second central nervous system relapse of neuroblastoma
Kathryn R Tringale, Suzanne L Wolden, Dana L Casey, et al.
Practical Radiation Oncology
|
February 4, 2024
Intraoperative Radiation Therapy for Relapsed or Refractory High-Risk Neuroblastoma: A 27-Year Experience
Brianna Conte, Dana L Casey, Kathryn R Tringale, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 21, 2025
Local Control With Reduced-Dose Radiation Therapy for High-Risk Neuroblastoma: Results From a Prospective Clinical Trial
Christopher B Jackson, Dana L Casey, Brian H Kushner, et al.
Journal of Neuro-Oncology
|
November 6, 2009
Compartmental intrathecal radioimmunotherapy: results for treatment for metastatic CNS neuroblastoma
Kim Kramer, Brian H Kushner, Shakeel Modak, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 15, 2017
Biodistribution and Dosimetry of <sup>18</sup>F-Meta-Fluorobenzylguanidine: A First-in-Human PET/CT Imaging Study of Patients with Neuroendocrine Malignancies
Neeta Pandit-Taskar, Pat Zanzonico, Kevin D Staton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 29, 2020
B7H3-Directed Intraperitoneal Radioimmunotherapy With Radioiodinated Omburtamab for Desmoplastic Small Round Cell Tumor and Other Peritoneal Tumors: Results of a Phase I Study
Shakeel Modak, Pat Zanzonico, Milan Grkovski, et al.
Research Square
|
November 21, 2023
Targeting GD2-positive Refractory/Resistant Neuroblastoma and Osteosarcoma with Anti- CD3 x Anti-GD2 Bispecific Antibody Armed T cells
Maxim Yankelevich, Archana Thakur, Shakeel Modak, et al.
Page
of 14